NASDAQ$TWST
Twist Bioscience Corporation · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Reported record revenue and improved gross margin.
Twist Bioscience reported a strong fiscal third quarter with record revenue of $81.5 million, a 28% increase year-over-year, and a gross margin improvement to 43.3%. The company exceeded revenue guidance and targets for cash burn and gross margin.
- Total revenue for the third quarter of fiscal 2024 grew to $81.5 million, a 28% increase compared to the same period in 2023.
- Gross margin increased to 43.3% in the third quarter of fiscal 2024, up approximately 900 basis points from 34.4% in the same period last year.
- The company shipped products to approximately 2,300 customers and approximately 212,000 genes during the quarter.
- Twist Bioscience increased full year 2024 revenue guidance to approximately $310 million to $311 million and expects gross margin at the high end of the range at approximately 42.0%.
Headline financials
Revenue & EPS history
Twist Bioscience · Revenue · Quarterly
$81.5M
Revenue by segment
Twist Bioscience · $218M total across 2 segments · Q3 2023
- NGS Applications$120M+23.7%55.0%
- DNA Synthesis & Protein$98M+22.5%45.0%
Forward guidance
Twist Bioscience provided updated financial guidance for fiscal year 2024, including increased revenue expectations and gross margin.
Tailwinds
- Total revenue is expected to be approximately $310 million to $311 million, indicating year-over-year growth of approximately 27%.
- SynBio revenue is expected to be approximately $121 million, indicating year-over-year growth of 23%.
- NGS revenue is expected to be in the range of $169 million to $170 million, indicating year-over-year growth of 36% to 37%.
- Gross margin is expected to be approximately 42.0% for fiscal 2024.
- Ending cash, cash equivalents and short-term investments at September 30, 2024 of more than $255 million.
Headwinds
- Biopharma revenue is expected to be approximately $20 million, indicating year-over-year decrease of approximately 13%.
- Loss from operations before taxes of approximately $227 million to $230 million, inclusive of the approximately $45 million impairment charge
- For the fourth quarter of fiscal year 2024, Twist expects adjusted EBITDA loss of $20 million.
- The company expects total revenue of approximately $82 million to $83 million for Q4 2024.
- The company expects gross margin of approximately 44% for Q4 2024.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
+0.1%
Avg return
Earnings day
-2.1%
Avg return
5 days after
+0.8%
Avg return
30 days after
47%
14 / 30 earnings
Positive
+29.7%
Q4 2023
Best reaction
-23.2%
Q1 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | -7.3% | -5.9% | +19.6% | |
| Q1 2026 | +13.8% | -5.9% | -10.2% | |
| Q4 2025 | -10.0% | -14.9% | +3.4% | |
| Q2 2025 | -8.5% | -16.9% | -20.8% | |
| Q1 2025 | +0.7% | -0.1% | -19.7% | |
| Q4 2024 | +12.0% | +14.5% | +20.9% | |
| Q3 2024 | -14.6% | -16.0% | -18.5% | |
| Q2 2024 | +28.9% | +34.9% | +31.1% | |
| Q1 2024 | +9.5% | +5.1% | +16.9% | |
| Q4 2023 | +29.7% | +24.9% | +81.5% | |
| Q3 2023 | +14.9% | +9.3% | +14.0% | |
| Q2 2023 | +3.6% | +2.1% | +26.0% | |
| Q1 2023 | -23.2% | -15.2% | -37.1% | |
| Q4 2022 | +0.8% | +0.5% | -0.6% | |
| Q3 2022 | +20.8% | +12.4% | -17.2% | |
| Q2 2022 | -9.9% | -16.3% | -12.6% | |
| Q1 2022 | -1.0% | +6.0% | -21.0% | |
| Q4 2021 | -12.6% | -14.1% | -22.4% | |
| Q3 2021 | -9.1% | -15.8% | -7.6% | |
| Q2 2021 | +6.2% | -9.4% | -12.4% | |
| Q1 2021 | -16.8% | -5.5% | -38.1% | |
| Q4 2020 | -9.9% | -0.8% | +44.3% | |
| Q3 2020 | -7.2% | -16.3% | -4.8% | |
| Q2 2020 | +5.1% | +4.6% | +0.7% | |
| Q1 2020 | +21.3% | +14.0% | +31.4% | |
| Q4 2019 | +4.6% | +5.8% | -15.5% | |
| Q3 2019 | -11.2% | -11.8% | -13.9% | |
| Q2 2019 | -9.9% | -9.7% | -3.9% | |
| Q1 2019 | -9.2% | -11.8% | -6.9% | |
| Q4 2018 | -9.2% | -9.4% | +18.6% | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2017 | — | — | — | |
| Q4 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro